Green Spring SARS-CoV-2 新冠快速抗原检测试剂 一盒10剂装

Package and Specification

Description

In vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in swab specimen within the first 5-7 days after onset of COVID-19 symptoms.

Product Advantages

1. Nasopharynx swab specimen, non-invasive

2. Very simple to use

3. Convenient, no devices required

4. Rapid, results within 20 minutes

5. Cost-efficient

Clinical report from local CDC

Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.

Component

1 test/bag X 10 bag

Desiccant x 10 packs

0.5mL extraction buffer x 10 bottles

Single-use reaction tube x 10

Sterile single-use sampling swab x 10